 "alkemlabs.com")
Alkem Laboratories rallied 7.5% to Rs 2,015 on the BSE in intra-day trade, extending its 3.5% gain in past three trading sessions, after the company reported 25% year on year (YoY) growth in consolidated net profit at Rs 233 crore for the quarter ended December 2016 (Q3FY17).
Total income from operations during the quarter under review rose by 15% at Rs 1,482 crore on YoY basis. The company said its US business contributed with strong revenue growth during the quarter driven mainly by market share gains.
EBITDA (earnings before interest, tax, depreciation and amortization) margin however remain unchanged
Total income from operations during the quarter under review rose by 15% at Rs 1,482 crore on YoY basis. The company said its US business contributed with strong revenue growth during the quarter driven mainly by market share gains.
EBITDA (earnings before interest, tax, depreciation and amortization) margin however remain unchanged
